RNA-based Therapies Market to Reach USD 213.54 Billion by 2033, Driven by Rare Diseases, Oncology, and Advances in RNA Technologies | DataM Intelligence

According to DataM Intelligence, "The RNA-Based Therapies Market Size, valued at USD 90.56 billion in 2024, is projected to ...
TMCnet

IMUNON Presents IMNN-001 Phase 2 Translational Data in Advanced Ovarian Cancer Demonstrating 13-Month OS Extension via Tumor Micro-Environment Shift

IMNN-001 continues to show a favorable safety profile.

New gene therapy hub opens in N.J., bringing 110 jobs and ‘hope for patients waiting for cures’

ProBio recently opened a gene therapy hub in a 128,000-square-foot facility in Mercer County, bringing more than 100 ...

Chinese national in fungus smuggling case to have plea hearing, sentencing in November

A plea hearing and sentencing are set for November for a Chinese national accused of smuggling into the United States a fungus that federal prosecutors said can causes a disease in crops.
The Manila Times

IMUNON to Present New Translational Data of IMNN-001 Supporting Phase 3 Trial of Immunotherapy for Ovarian Cancer at AACR Special Conference in Cancer Research

OVATION 3 pivotal Phase 3 trial is currently advancing IMNN-001, with several patients being treated ...
TipRanks on MSN

Imunon to present translational data from Phase 2 OVATION 2 Study of IMNN-001

IMUNON (IMNN) announced that new translational data from the Phase 2 OVATION 2 Study of IMNN-001, its investigational therapy for the treatment of ...